United Therapeutics reported $27.7B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 290M 51M Dec/2025
Ardelyx USD 718M 542M Nov/2026
Baxter International USD 12.41B 1.4B Sep/2026
Bayer EUR 52.42B 5.31B Nov/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Biogen USD 33.38B 1.48B Sep/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Halozyme Therapeutics USD 15.62B 3.09B Nov/2026
Insmed USD 24.93B 1.82B Sep/2026
Ionis Pharmaceuticals USD 4.52B 2.9B Nov/2026
J&J USD 653.61B 42.25B Sep/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Moderna USD 99.14B 22.26B Nov/2026
Pfizer USD 165.12B 1.71B Nov/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
Teva Pharmaceutical Industries USD 153.58B 106.85B Nov/2026
United Therapeutics USD 28.64B 5.4B Nov/2026
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026